PRA Expert to Present at Pharmacovigilance Conference
RALEIGH, N.C., Nov. 22, 2011 /PRNewswire/ — PRA, a leading Clinical Research Organization, announces that the head of our Safety and Risk Management (SRM) group will speak at VIBPharma’s 7th Annual Pharmacovigilance, Drug Safety and Risk Management conference being held in Brussels, Belgium from 22-23 November 2011. PRA will also host an exhibit at booth #1, where additional SRM representatives will be available to discuss PRA’s approach to pharmacovigilance.
On 22 November at 11:10AM CET, Dr. Sabine Richter, PRA’s Vice President of SRM, will deliver a presentation titled, “Rationalising How Outsourcing Pharmacovigilance Activities Can Strengthen Your Regulatory Compliance and Immensely Increase Flexibility.” Dr. Richter will discuss the key benefits of outsourcing drug safety services, review best practices for vendor management, and explore risk-sharing techniques that create effective cost reductions.
Dr. Richter has over 25 years of research experience in the pharmaceutical and clinical research industries as well as in academia. Since joining PRA’s SRM team in 2004, she has delivered numerous projects for a variety of clients and led large, long-term safety programs involving as many as 50 countries on five continents. As the head of PRA’s SRM group, Dr. Richter has developed robust procedures and quality control measures to ensure consistent high performance and regulatory compliance.
PRA’s SRM group provides services throughout the entire product life cycle. The team includes over 100 experts available to clients for consultancy as well as routine and specialty pharmacovigilance services. Most of these staff members are healthcare professionals (nurses, pharmacists, physicians) or life scientists. PRA’s drug safety centers are based in our Mannheim, Germany; Swansea, UK; Charlottesville, VA (US); and Sao Paulo, Brazil offices.
PRA is transforming clinical trials through our people, innovation and transparency. PRA provides personalized service customized to the unique requirements of each study. We support our global reach and innovative approach through flexible and reliable service, delivered by skilled employees dedicated to ensuring that sponsors achieve their long-term goals.
We serve our clients across all phases of pharmaceutical and biotech drug development by combining therapeutic and operational expertise with local knowledge. Offering services in 80+ countries and serving sponsors for 30+ years, we have amassed a level of expertise that has enabled us to work on a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs. But at PRA, we are looking to the future, not the past. Our increasingly forward-thinking approach to transforming the clinical trial landscape will continue to make a difference to healthcare patients around the world.